2023-05-10 17:35:35 ET
- Spero Therapeutics ( NASDAQ: SPRO ) is scheduled to announce Q1 earnings results on Thursday, May 11th, after market close.
- The consensus EPS Estimate is -$0.26 (+74.3% Y/Y) and the consensus Revenue Estimate is $1.27M (-38.6% Y/Y).
- Over the last 1 year, SPRO has beaten EPS estimates 0% of the time and has beaten revenue estimates 50% of the time.
- Over the last 3 months, EPS estimates have seen 1 upward revision and 0 downward. Revenue estimates have seen 1 upward revision and 0 downward.
For further details see:
Spero Therapeutics Q1 2023 Earnings Preview